NEW YORK, Sept. 19, 2013 /PRNewswire-USNewswire/ -- A national survey of 1,000 women showed that 62% preferred the concept of a non-hormonal contraceptive ring over hormonal methods.
The objective of the survey, conducted in July by Field Agent™, a leader in mobile research and data collection, was to understand the willingness of women-contraceptive users to switch to a safer, non-hormonal, yet equally effective vaginal ring product. Such a product was invented and patented by BioRings LLC, a not-for-profit developer of multi-purpose preventative technology (MPT) for female reproductive health.
BioRings' laboratory research was originally conducted by a team at Weill-Cornell Medical College (NYC), led by the late Dr. Brij Saxena and Dr. Mukul Singh. Work on the product continues within BioRings LLC under the direction of co-inventors Sidney Lerner, BioRings' president, clinician Dr. Mukul Singh, and advisors Arnold Burstein & Jeffrey McElnea.
The goal of the consumer survey was to collect relevant data from a random sample of 1,000 women who currently use contraceptives. The cross-tabulated report has provided clear evidence that women, especially younger and higher educated, would accept the ring form of contraception and prefer the non-hormonal option to currently available hormonal methods.
The public health community has been supportive of women-controlled contraceptive methods and their global impact on female health. At the Product Prioritization Stakeholders Meeting held in Washington DC, it was confirmed by experts at USAID, CAMI, Mary Wohlford Foundation and Public Health Institute that "Non-hormonal options for contraception are a clear priority, given their potential for fewer side effects and use in 'on demand' products." It is time that non-hormonal female contraception be fully developed and available.
Survey questions included the combination of quantitative and qualitative response options to gain an understanding of what variables relate to the willingness to switch. The demographic variables included age, ethnicity, income and education, alongside additional identifiers.
Still in early-stage development, BioRings' three natural ingredients are time-released over the users' 28-day cycle. Like hormonal vaginal rings currently on the market, BioRings are self-administered monthly and have tested highly effective in the laboratory.
SOURCE The Monday Campaigns